We serve Chemical Name:methyl carbonate,triethyl(methyl)azanium CAS:113840-08-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:methyl carbonate,triethyl(methyl)azanium
CAS.NO:113840-08-7
Synonyms:Methyltriethylammonium methyl carbonate;Triethylmethylammonium methyl carbonate solution;Triethylmethylammonium methyl carbonate
Molecular Formula:C9H21NO3
Molecular Weight:191.26800
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:n20/D 1.407
PSA:49.36000
Exact Mass:191.15200
LogP:0.46880
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 1987 3/PG 3
Packing Group:
Contact us for information like Methyltriethylammonium methyl carbonate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Triethylmethylammonium methyl carbonate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methyltriethylammonium methyl carbonate Use and application,Methyltriethylammonium methyl carbonate technical grade,usp/ep/jp grade.
Related News: ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment��s chemistry, manufacturing and controls process, but not its safety. methyl carbonate,triethyl(methyl)azanium manufacturer Targets within the tumor microenvironment may include both plasma membrane proteins as well as proteins typically secreted into the extracellular space. methyl carbonate,triethyl(methyl)azanium supplier ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment��s chemistry, manufacturing and controls process, but not its safety. methyl carbonate,triethyl(methyl)azanium vendor The Big Pharma had, however, decided to all but shelve donanemab in the near term as it couldn’t see a regulatory path forward. methyl carbonate,triethyl(methyl)azanium factory The Big Pharma had, however, decided to all but shelve donanemab in the near term as it couldn’t see a regulatory path forward.
